chrX-49243407-G-A
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_014008.5(CCDC22):c.659G>A(p.Arg220Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000227 in 1,202,312 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 84 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R220W) has been classified as Uncertain significance.
Frequency
Consequence
NM_014008.5 missense
Scores
Clinical Significance
Conservation
Publications
- Ritscher-Schinzel syndrome 2Inheritance: XL Classification: STRONG, MODERATE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
- Ritscher-Schinzel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsyInheritance: XL Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CCDC22 | NM_014008.5 | c.659G>A | p.Arg220Gln | missense_variant | Exon 6 of 17 | ENST00000376227.4 | NP_054727.1 | |
| CCDC22 | XM_005272599.5 | c.656G>A | p.Arg219Gln | missense_variant | Exon 6 of 17 | XP_005272656.1 | ||
| CCDC22 | XR_430506.4 | n.826G>A | non_coding_transcript_exon_variant | Exon 6 of 11 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CCDC22 | ENST00000376227.4 | c.659G>A | p.Arg220Gln | missense_variant | Exon 6 of 17 | 1 | NM_014008.5 | ENSP00000365401.3 | ||
| CCDC22 | ENST00000496651.5 | n.750G>A | non_coding_transcript_exon_variant | Exon 6 of 6 | 3 | |||||
| CCDC22 | ENST00000490300.1 | n.*61G>A | downstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000240 AC: 27AN: 112600Hom.: 0 Cov.: 24 show subpopulations
GnomAD2 exomes AF: 0.000291 AC: 47AN: 161441 AF XY: 0.000254 show subpopulations
GnomAD4 exome AF: 0.000226 AC: 246AN: 1089659Hom.: 0 Cov.: 31 AF XY: 0.000216 AC XY: 77AN XY: 356639 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000240 AC: 27AN: 112653Hom.: 0 Cov.: 24 AF XY: 0.000201 AC XY: 7AN XY: 34821 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:3
CCDC22: BP4, BS2 -
- -
- -
not specified Uncertain:1Benign:1
- -
The c.659G>A (p.R220Q) alteration is located in exon 6 (coding exon 6) of the CCDC22 gene. This alteration results from a G to A substitution at nucleotide position 659, causing the arginine (R) at amino acid position 220 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at